Home Cart 0 Sign in  
X

[ CAS No. 5447-02-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 5447-02-9
Chemical Structure| 5447-02-9
Chemical Structure| 5447-02-9
Structure of 5447-02-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5447-02-9 ]

Related Doc. of [ 5447-02-9 ]

Alternatived Products of [ 5447-02-9 ]

Product Details of [ 5447-02-9 ]

CAS No. :5447-02-9 MDL No. :MFCD00004776
Formula : C21H18O3 Boiling Point : -
Linear Structure Formula :- InChI Key :XDDLXZHBWVFPRG-UHFFFAOYSA-N
M.W : 318.37 Pubchem ID :79526
Synonyms :

Calculated chemistry of [ 5447-02-9 ]

Physicochemical Properties

Num. heavy atoms : 24
Num. arom. heavy atoms : 18
Fraction Csp3 : 0.1
Num. rotatable bonds : 7
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 93.79
TPSA : 35.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.25 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.15
Log Po/w (XLOGP3) : 4.21
Log Po/w (WLOGP) : 4.35
Log Po/w (MLOGP) : 3.43
Log Po/w (SILICOS-IT) : 5.1
Consensus Log Po/w : 4.05

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.56
Solubility : 0.00879 mg/ml ; 0.0000276 mol/l
Class : Moderately soluble
Log S (Ali) : -4.67
Solubility : 0.00687 mg/ml ; 0.0000216 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -7.65
Solubility : 0.00000713 mg/ml ; 0.0000000224 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.31

Safety of [ 5447-02-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5447-02-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5447-02-9 ]
  • Downstream synthetic route of [ 5447-02-9 ]

[ 5447-02-9 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 100-39-0 ]
  • [ 139-85-5 ]
  • [ 5447-02-9 ]
  • [ 4049-39-2 ]
  • [ 50773-56-3 ]
Reference: [1] Helvetica Chimica Acta, 2002, vol. 85, # 7, p. 2009 - 2055
[2] European Journal of Organic Chemistry, 2018, vol. 2018, # 18, p. 2053 - 2063
  • 2
  • [ 100-39-0 ]
  • [ 139-85-5 ]
  • [ 5447-02-9 ]
  • [ 4049-39-2 ]
Reference: [1] Chemistry - A European Journal, 2016, vol. 22, # 9, p. 2935 - 2938
[2] European Journal of Organic Chemistry, 2018, vol. 2018, # 18, p. 2053 - 2063
  • 3
  • [ 100-44-7 ]
  • [ 139-85-5 ]
  • [ 5447-02-9 ]
  • [ 4049-39-2 ]
  • [ 50773-56-3 ]
Reference: [1] Journal of the Chemical Society, Chemical Communications, 1985, # 6, p. 311 - 314
  • 4
  • [ 5447-02-9 ]
  • [ 4049-39-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1999, vol. 42, # 6, p. 1076 - 1087
  • 5
  • [ 5447-02-9 ]
  • [ 27688-86-4 ]
YieldReaction ConditionsOperation in experiment
86%
Stage #1: With 3-chloro-benzenecarboperoxoic acid In dichloromethane; water at 0℃; for 7.5 h; Inert atmosphere
Stage #2: at 20℃; for 1 h; Inert atmosphere
General procedure: Under an argon atmosphere, m-chloroperbenzoic acid (contains ca 30percent water, purity >65percent, 41.7 g, ca. 157 mmol) was addedportionwise to a solution of S6 (25.3 g, 105 mmol) in dichloromethane (160 mL) at 0 °C.After stirring for 7.5 h, the reaction mixture was quenched with saturated aqueousNaHCO3. The mixture was diluted with water and the organic layer was separated. The aqueouslayer was extracted with dichloromethane. The combined extracts were washed with saturated aqueous NaHCO3, water, and brine, dried over Na2SO4, and evaporated. The residue was dissolvedin methanol (300 mL) and K2CO3 (72.3 g, 523 mmol) was added portionwise to the solution atroom temperature. After stirring for 1 h, the mixture was evaporated under reduced pressure. Waterwas added to the residue and the product was extracted with diethyl ether. The extract was washedwith water and brine, dried over Na2SO4, and evaporated. The residue was recrystallized fromdiethyl ether-hexane to give S7 as pale yellow granules (14.7 g, 61percent). The mother liquor from theabove recrystallization was evaporated and the residue was chromatographed over silica gel 60N (hexane–ethyl acetate = 3:1) to give an additional S7 as pale yellow solid (3.14 g, 13percent). The totalyield of S7 was 17.8 g (74percent).
Reference: [1] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1993, # 11, p. 2165 - 2170
[2] Journal of Organic Chemistry, 2003, vol. 68, # 22, p. 8500 - 8504
[3] Heterocycles, 2014, vol. 89, # 1, p. 59 - 68
[4] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 24, p. 6563 - 6580
[5] Tetrahedron, 2005, vol. 61, # 34, p. 8101 - 8108
[6] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 3, p. 283 - 286
[7] Chemical and Pharmaceutical Bulletin, 1983, vol. 31, # 9, p. 3024 - 3038
[8] Chemical and Pharmaceutical Bulletin, 1991, vol. 39, # 7, p. 1736 - 1745
[9] Heterocycles, 1996, vol. 43, # 3, p. 665 - 674
[10] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 23, p. 7962 - 7966
[11] European Journal of Medicinal Chemistry, 1999, vol. 34, # 6, p. 539 - 548
[12] Tetrahedron, 1998, vol. 54, # 21, p. 5635 - 5650
[13] Tetrahedron Letters, 1997, vol. 38, # 13, p. 2325 - 2328
[14] Organic Letters, 2011, vol. 13, # 10, p. 2714 - 2717
[15] European Journal of Organic Chemistry, 2012, # 20, p. 3863 - 3870
[16] Nature Communications, 2017, vol. 8, # 1,
  • 6
  • [ 5447-02-9 ]
  • [ 1570-05-4 ]
Reference: [1] Archiv der Pharmazie, 1997, vol. 330, # 9-10, p. 313 - 316
[2] Bioorganic and Medicinal Chemistry, 1997, vol. 5, # 9, p. 1873 - 1882
[3] Yakugaku Zasshi, 1952, vol. 72, p. 1081,1083[4] Chem.Abstr., 1953, p. 10536
[5] Helvetica Chimica Acta, 1962, vol. 45, p. 270 - 276
[6] Archives of Pharmacal Research, 2011, vol. 34, # 7, p. 1065 - 1070
  • 7
  • [ 5447-02-9 ]
  • [ 1570-05-4 ]
  • [ 189082-97-1 ]
Reference: [1] European Journal of Medicinal Chemistry, 1999, vol. 34, # 6, p. 539 - 548
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 5447-02-9 ]

Aryls

Chemical Structure| 1700-37-4

[ 1700-37-4 ]

3-Benzyloxybenzaldehyde

Similarity: 0.95

Chemical Structure| 4397-53-9

[ 4397-53-9 ]

4-(Benzyloxy)benzaldehyde

Similarity: 0.93

Chemical Structure| 80407-64-3

[ 80407-64-3 ]

3,4-Bis(2-methoxyethoxy)benzaldehyde

Similarity: 0.93

Chemical Structure| 1131-52-8

[ 1131-52-8 ]

3-Ethoxy-4-methoxybenzaldehyde

Similarity: 0.93

Chemical Structure| 120-25-2

[ 120-25-2 ]

4-Ethoxy-3-methoxybenzaldehyde

Similarity: 0.93

Aldehydes

Chemical Structure| 1700-37-4

[ 1700-37-4 ]

3-Benzyloxybenzaldehyde

Similarity: 0.95

Chemical Structure| 29668-44-8

[ 29668-44-8 ]

2,3-Dihydrobenzo[b][1,4]dioxine-6-carbaldehyde

Similarity: 0.93

Chemical Structure| 80407-64-3

[ 80407-64-3 ]

3,4-Bis(2-methoxyethoxy)benzaldehyde

Similarity: 0.93

Chemical Structure| 1131-52-8

[ 1131-52-8 ]

3-Ethoxy-4-methoxybenzaldehyde

Similarity: 0.93

Chemical Structure| 120-25-2

[ 120-25-2 ]

4-Ethoxy-3-methoxybenzaldehyde

Similarity: 0.93

Ethers

Chemical Structure| 1700-37-4

[ 1700-37-4 ]

3-Benzyloxybenzaldehyde

Similarity: 0.95

Chemical Structure| 4397-53-9

[ 4397-53-9 ]

4-(Benzyloxy)benzaldehyde

Similarity: 0.93

Chemical Structure| 80407-64-3

[ 80407-64-3 ]

3,4-Bis(2-methoxyethoxy)benzaldehyde

Similarity: 0.93

Chemical Structure| 1131-52-8

[ 1131-52-8 ]

3-Ethoxy-4-methoxybenzaldehyde

Similarity: 0.93

Chemical Structure| 120-25-2

[ 120-25-2 ]

4-Ethoxy-3-methoxybenzaldehyde

Similarity: 0.93